找回密码
 注 册

QQ登录

只需一步,快速开始

新浪微博登陆

只需一步, 快速开始

手机号码,快捷登录

首页 电子烟 加热不燃烧 查看内容

菲莫国际韩国公司呼吁对加热不燃烧烟草制品制定单独的监管规定

IT007编辑02 2020-10-10 10:25

近日,Philip Morris韩国公司在宣传其IQOS已获得美国食品药品监督管理局(FDA)授权的同时,呼吁政府应针对加热不燃烧烟草制品制定单独的规定。

今年7月FDA授权菲莫国际的加热不燃烧烟草制品作为一种改良风险烟草产品进行营销,这是该行业的第一款产品。该公司表示,将提供FDA所需的任何其他信息,以获得IQOS作为“降低风险”产品的市场推广权。

641

PMK常务董事Paik Young-jay在现场直播的新闻发布会上表示“如果成年吸烟者获得了错误的信息,并且没有(使用加热不燃烧的)政策来帮助他们,他们将继续抽普通香烟,这是最有害的选择。”

该公司再次呼吁政府追随美国的脚步,根据科学证据制定政策。

近几个月来,韩国已经提出了多项法案,以加强对加热不燃烧烟草制品的监管,包括增加税收和要求贴有健康警示标签。

FDA已经承认,这些产品已经“改变了”与烟草使用有关的风险,而PMK正在推动当局认识到,这种风险不仅改变了,而且“减少了”。

PMK还指出,FDA一般不会批准烟草产品,而IQOS也不是没有风险的。

小雨商城是喜科CIGOO的独家代理,将会为你持续带来更多加热不燃烧行业新闻以及喜科CIGOO烟弹的更多消息。

IMG_8241.JPEG


641

Philip Morris Korea says Iqos brings ‘reduced risk’
Calls for separate regulations for heated cigarettes citing FDA’s recognition of ‘modified risk’
Managing Director at Philip Morris Korea Paik Young-jay (Philip Morris Korea)
Philip Morris Korea on Wednesday called on the government to introduce separate regulations for heat-not-burn cigarettes as it touted the authorization by the US Food and Drug Administration of its Iqos.
The FDA decided in July to authorize the marketing of the company‘s electronically heated tobacco system as a modified risk tobacco product as the industry‘s first. The company said it will also provide any additional information required by the FDA to acquire the right to market Iqos as “reduced risk” products going forward.
“If adult smokers are given incorrect information and policy to help them switch (to electronic cigarettes) doesn’t exist, they will continue to smoke regular cigarettes, which is the most harmful [choice],” said Paik Young-jay, Managing Director at PMK during a livestreamed press conference.
The company refreshed calls on the government to follow the footsteps of the US and set policies based on scientific evidence.
The comments come as the government has proposed multiple bills in recent months to toughen regulations on heated cigarettes, including a tax increase and requiring health warning labels.
The FDA has acknowledged the products have “modified” the risk associated with tobacco use, while PMK is pushing for the authority to recognize the risk has not only been modified but also “reduced.”
PMK also noted that the FDA itself doesn’t “approve” of tobacco products in general and that Iqos is also not risk-free.


    原作者: 小雨商城
    分享到
    文章点评

    相关分类

    推荐阅读